How have RVPHW shares performed in 2024?

Reviva Pharmaceuticals' stock was trading at $1.43 at the beginning of the year. Since then, RVPHW stock has decreased by 67.1% and is now trading at $0.47. View the best growth stocks for 2024 here .

Are investors shorting Reviva Pharmaceuticals?

Reviva Pharmaceuticals saw a decline in short interest in April. As of April 15th, there was short interest totaling 13,100 shares, a decline of 16.0% from the March 31st total of 15,600 shares. Based on an average daily volume of 16,600 shares, the days-to-cover ratio is currently 0.8 days. View Reviva Pharmaceuticals' Short Interest .

How do I buy shares of Reviva Pharmaceuticals?

Shares of RVPHW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:RVPHW

Reviva Pharmaceuticals (RVPHW) Stock Price, News & Analysis

→ “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad)

Free RVPHW Stock Alerts

$0.47

-0.03 (-6.00%)

(As of 04/25/2024 ET)

Compare

Today's Range: $0.42
▼
$0.51
50-Day Range: $0.47
▼
$1.01
52-Week Range: $0.40
▼
$3.00

Volume: 22,348 shs
Average Volume: 16,763 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials SEC Filings Short Interest Social Media

Get Reviva Pharmaceuticals alerts:

Ad Stansberry Research

“Retirement Secret” Showed 995% Gain Last Time We Shared It

Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.

Find out why right here (and see what you can do to get in too with just a few dollars).

About Reviva Pharmaceuticals

Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. It is also developing RP1208 that is in pre-clinical development studies for the treatment of depression and obesity. The company was founded in 2018 and is based in Cupertino, California.

RVPHW Stock Price History

30 days | 90 days | 365 days | Advanced Chart

RVPHW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive RVPHW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: NASDAQ:RVPHW
CUSIP: N/A
CIK: 1742927
Web: N/A
Phone: 408-501-8881
Fax: N/A
Employees: 10
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

Dr. Laxminarayan Bhat Ph.D. (Age 59)
Founder, CEO, President & Director
Comp: $560k
Mr. Narayan Prabhu (Age 52)
Chief Financial Officer
Comp: $412.5k

Key Competitors

View All Competitors

RVPHW Stock Analysis - Frequently Asked Questions

How have RVPHW shares performed in 2024?: Reviva Pharmaceuticals' stock was trading at $1.43 at the beginning of the year. Since then, RVPHW stock has decreased by 67.1% and is now trading at $0.47.
View the best growth stocks for 2024 here.
Are investors shorting Reviva Pharmaceuticals?: Reviva Pharmaceuticals saw a decline in short interest in April. As of April 15th, there was short interest totaling 13,100 shares, a decline of 16.0% from the March 31st total of 15,600 shares. Based on an average daily volume of 16,600 shares, the days-to-cover ratio is currently 0.8 days.
View Reviva Pharmaceuticals' Short Interest.
How do I buy shares of Reviva Pharmaceuticals?: Shares of RVPHW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:RVPHW) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial